Australia's most trusted
source of pharma news
Saturday, 19 July 2025
Posted 4 July 2025 AM
MSAC has cut burdensome red tape for pharmas knocked back in their quest for public funding by introducing a simplified process to reapply this month.
Most companies looking to commercialise their targeted therapies in Australia apply to MSAC to determine the eligibility of their drugs on the PBS.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.